In the 35 years before the COVID-19 pandemic, the U.S. government invested at least $337 million into critical research that led to the mRNA COVID-19 vaccines, according to a study published by The BMJ today.
Mar 1, 2023
0
88
A personalized cancer vaccine developed with the help of a Mount Sinai computational platform raised no safety concerns and showed potential benefit in patients with different cancers, including lung and bladder, that have ...
Apr 11, 2021
0
152
Almost 95 percent of Australians aged 16 and over are now fully vaccinated against COVID-19. Globally, around 65 percent of adults have had at least one dose of the vaccines available including Moderna, AstraZeneca, Janssen ...
Sep 5, 2022
0
45
The prestigious journal Science on Thursday published an editorial calling for a global effort to develop a universal coronavirus vaccine that would remain effective against other members of the same virus family that might ...
Feb 18, 2021
1
97
Vaccination has changed the profile of hospitalized COVID-19 patients and people who die from the disease in Brazil. A study conducted in São José do Rio Preto, in the state of São Paulo, Brazil, reports on the start of ...
Feb 24, 2022
0
31
Nearly four decades after its discovery, HIV has killed 36.3 million people, with no vaccine in sight. However, a new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, ...
Feb 4, 2022
0
180
For the first time in the world: a team of researchers from Tel Aviv University and the Israel Institute for Biological Research have developed an mRNA-based vaccine that is 100% effective against a type of bacteria that ...
Mar 9, 2023
0
190
Levels of antibodies in the blood of vaccinated people that are able to recognise and fight the new SARS-CoV-2 Delta variant first discovered in India (B.1.617.2) are on average lower than those against previously circulating ...
Jun 4, 2021
0
25
A vaccine being developed at the Oxford University against COVID-19 could see an Indian roll-out in December, experts say.
Nov 16, 2020
0
4
A team of University of Maryland researchers developed a nasal spray vaccine that delivers the SARS-CoV-2 spike protein into cells of the airway in mice and hamsters, triggering an immune response that significantly reduced ...
Nov 6, 2023
0
72
